2022年

  • Data for method development of water droplet-in-oil digestion approach
    Takeshi Masuda, Norie Araki, Sumio Ohtsuki
    Journal of Proteome Method and Data in press 2023年2月
  • SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice
    Tatsuya Yoshizawa, Yoshifumi Sato, Shihab U. Sobuz, Tomoya Mizumoto, Tomonori Tsuyama, Md. Fazlul Karim, Keishi Miyata, Masayoshi Tasaki, Masaya Yamazaki, Yuichi Kariba, Norie Araki, Eiichi Araki, Shingo Kajimura, Yuichi Oike, Thomas Braun, Eva Bober, Johan Auwerx, Kazuya Yamagata
    Nature Communications 13(1) 2022年12月12日
  • Water Droplet-in-Oil Digestion Method for Single-Cell Proteomics
    Takeshi Masuda, Yuma Inamori, Arisu Furukawa, Maki Yamahiro, Kazuki Momosaki, Chih-Hsiang Chang, Daiki Kobayashi, Hiroto Ohguchi, Yawara Kawano, Shingo Ito, Norie Araki, Shao-En Ong, Sumio Ohtsuki
    Analytical Chemistry 94 10329-10336 2022年7月11日(査読有)

2021年

  • A protocol for analyzing the protein terminome of human cancer cell line culture supernatants,
    Kazuya Tsumagari, Chih HsiangChang, Yasushi Ishihama, STAR Protocols, 2, pp. 100682, September 2021(査読有).
  • Sequence-Specific Model for Predicting Peptide Collision Cross Section Values in Proteomic Ion Mobility Spectrometry, Chih-Hsiang Chang, Darien Yeung, Victor Spicer, Kosuke Ogata, Oleg Krokhin, Yasushi Ishihama, Journal of Proteome Research, 20, pp. 3600–3610, June, 2021(査読有).
  • Exploringthelandscapeofectodomainsheddingbyquantitative protein terminomics, KazuyaTsumagari, Chih-Hsiang Chang, Yasushi Ishihama, iScience, 24, pp. 102259, April, 2021(査読有).
  • IsolationofAcetylatedandUnmodifiedProteinN- Terminal Peptides by Strong Cation Exchange Chromatographic Separation of TrypN-Digested Peptides, Chih-Hsiang Chang, Hsin-Yi Chang, Juri Rappsilber, Yasushi Ishihama Molecular & Cellular Proteomics, 20, pp. 100003, January, 2021(査読有).
  • EffectofPhosphorylationontheCollisionCrossSectionsofPeptideIons in Ion Mobility Spectrometry,Kosuke Ogata, Chih-Hsiang Chang, Yasushi Ishihama, Mass spectrometry (Tokyo, Japan), 10, pp. A0093, January, 2021(査読有).

2020年

2019年

  • Kobayashi D, Tokuda T, Sato K, Okanishi H, Nagayama M, Hirayama M, Ohtsuki S, Araki N* Identification of a Specific Translational Machinery via TCTP–EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA). Molecular & cellular proteomics  18(2) 245-262, 2019  doi: 10.1074/mcp.RA118.001014.  PMID: 30381327
  • Daiki Kobayashia, Takaho Tokudaa, Kyosuke Satob, Hiroki Okanishia, Megumi Nagayamaa, Mio Hirayama-Kurogic, Sumio Ohtsukic, Norie Araki*. Identification of a Specific Translational Machinery via TCTP–EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA). Molecular & Cellular Proteomics 18(2) 245-262, 2019(査読有)     
  • Moriya Y, Kawano S, Okuda S, Watanabe Y, Matsumoto M, Takami T, Kobayashi D, Yamanouchi Y, Araki N, Yoshizawa AC, Tabata T, Iwasaki M, Sugiyama N, Tanaka S, Goto S*, Ishihama Y,*  The jPOST environment: an integrated proteomics data repository and database. Nucl Acids Res 2018 Volume 47, Issue D1, 08 January 2019, Pages D1218–D1224. (IF. 11.561) (査読有)  doi: 10.1093/nar/gky899. PMID:30295851

2018年

2017年以前

  • Hirayama M, Kobayashi D, MizuguchiS, Morikawa T, Nagayama M, Wilson MM, Nambu NA, YoshizawaA, KawanoS, and Araki N*. Integrated proteomics identified a novel activation signaling of dynein IC2-GR-COX-1 in NF1 disease model cells.  Molecular & Cellular Proteomics, 2013 12(5):1377-1394  [IF:7.3/5.232, citation:4]
  • Nambu, NA., Midorikawa U, Mizuguchi S, Hide T, Nagai M, Komohara Y, Nagayama1 M, Hirayama M, Kobayashi D, Tsubota N, Takezaki T, Makino K, Nakamura H, Takeya M, Kuratsu J and Araki N*. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrinαV. PLOS ONE, 2013 8(5):e59558, [IF:3.5/2.77, citation:1]
  • Yamamoto T, Nakayama K, Hirano H, Tomonaga T, Ishihama Y, Yamada T, Kondo T, Kodera Y, Sato Y, Araki N, Mamitsuka H, Goshima N. Integrated View of the Human Chromosome X-centric Proteome Project. J Proteome Res. 2013;12:58-61. [IF:5.0/3.95, citation:3]
  • Silsirivanit A, Araki N*, Wongkham C, Vaeteewoottacharn K, Pairojkul C, Kuwahara K, Narimatsu Y, Sawaki H, Narimatsu H, Okada S, Sakaguchi N, Wongkham S. CA-S27: A novel Lewis A associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Sci. 2013: 104(10):1278-84. doi: 10.1111/cas.12222.   [IF:3.5/4.372, citation:3]
  • Nitta H, Wada Y, Kawano Y, Murakami Y, Irie A, Taniguchi K, Kikuchi K, Yamada G, Suzuki K, Honda J, Wilson MM, Araki N, Eto M, Baba H and Imamura T.  Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a-receptor (CD88).  Clinical Cancer Research, 2013, 19(8); 1-10 [IF:8.2/10.199, citation:6]
  • Kuwano Y, Yoneda K, Kawaguchi Y, Araki N, Araki T. The complete amino acid sequence, and enzymatic properties of an i-type lysozyme isolated from the common orient clam (Meretrix lusoria) Bioscience Biotechnology, and Biochemistry, 2013 77(11):2269-77.    [IF:1.2/1.255, citation:1]
  • Shimada, H; Nambu-Niibori, A; Wilson-Morifuji, M; Mizuguchi, S; Araki, N*; Mezaki, Y; Senoo, H; Ishikawa, K; Okamoto, O; Fujiwara, S*. Epiplakin modifies the motility of the HeLa cells and accumulates at the outer surfaces of three-dimensional cell clusters.  J. Dermatol. 2013 40(4):249-58. [IF:2.4/2.788, citation:1]
  • Irie A, Harada K, Araki N, Nishimura Y.  Phosphorylation by PKD2 at Ser171 of SET reduced its inhibitory effect on PP2A phosphatase in T cells. PLosOne, 2012, ;7(12):e51242. doi: 10.1371 [IF:3.5/2.77, citation:3]
  • Sawanyawisuth1 K., Wongkham C, Riggins GJ., Wongkham S, Araki N*. Possible involvement of Cyclophilin A processing in fumagillin-induced suppression of cholangiocarcinoma cell proliferation. Asian Pac J Cancer Prev. 2012;13:137-41. [IF:2.514, citation:1]
  • Khaenam P., Niibori NM., Okada S.,, Jearanaikoon P., Araki N*, Limpaiboon T. Contribution of RIZ1 in proliferation and migration of liver fluke-related cholangiocarcinoma cell line.  Asian Pac J Cancer Prev. 2012;13(8):4007-11. [IF:1.5/2.514, citation:2]
  • SawanyawisuthK., WongkhamC., ArakiN., ZhaoQ, RigginsGJ., WongkhamS. Serial Analysis of Gene Expression Reveals Promising Therapeutic Targets for Liver Fluke-associated Cholangiocarcinoma.  Asian Pac J Cancer Prev. 2012;13:89-93. [IF:1.5/2.514, citation:4]
  • SilsirivanitA, Araki N*, Wongkham C, Pairojkul C, Narimatsu H, Kuwahara K, WongkhamS*, Sakaguchi N. A novel serum carbohydrate marker for cholangiocarcinoma: values for diagnostic and prognostic indicators.  Cancer. 117(15):3393-403, 2011  [IF:4.9/6.537, citation:14]
  • Esaki K, Terashima Y, Toda E, Yoshinaga S, Araki N, Matsushima K, Terasawa H.    Expression and purification of human FROUNT, a common cytosolicregulator of CCR2 and CCR5.  Protein Expr Purif. 2011 77(1):86-91, 2011 [IF:1.5/1.338, citation:3]
  • Nambu, T; Araki, N*; Nakagawa, A; Kuniyasu, A; Kawaguchi, T; Hamada, A; Saito, H. The Contribution of BCR-ABL-independent Activation of ERK1/2 to Acquired Imatinib Resistance in K562 Chronic Myeloid Leukemia Cells. Cancer Science, 2010, 101(1):137-42  [IF:3.5/4.372., citation:9]